BioWorld

April 13, 2006

Infinity Gaining Listing Through Merger With Discovery Partners

Privately held Infinity Pharmaceuticals Inc. is getting a stock listing through a reverse merger with publicly traded Discovery Partners International Inc., to further the former's anticancer portfolio. (BioWorld Today) Read More

CNS Firms Vanda, Targacept Price Initial Public Offerings

Development Moving Forward In Non-Embryonic Stem Cells

Renovis CEO: Beware Short Sellers' 'Shadowy' Influence

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...